| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Protein Kinase C in Human Astrocytomas Indicates a Role in Malignant Progression
Program in Neurosurgery, Departments of Clinical Neurosciences [D. L. B., M. H. E., P. W. F.] and Surgical Pathology [S. D. F.], Brown University and Rhode Island Hospital, Providence, Rhode Island 02903
Protein kinase C (PKC) is a family of isoenzymes which play an important role in regulating cell proliferation and differentiation. Constitutive activation of PKC, either by phorbol esters or overexpression of specific isoenzymes, leads to growth abnormalities in vitro and tumor promotion in vivo. Since stimulation of PKC in cultured astrocytes results in biochemical and morphological alterations associated with the transformed phenotype, we wanted to determine whether abnormal expression of specific isoenzymes of PKC was important in development of human astrocytomas in vivo.
We have detected a specific pattern of
-PKC expression in human astrocytomas which is noteworthy because the highest transcript levels were detected in well-differentiated (Grade 1) tumors, with intermediate expression in anaplastic (Grade 2) astrocytomas and low or nondetectable levels in glioblastomas (Grade 3 astrocytomas) and normal controls. In comparison, the ß-PKC transcript was not detected in any of the tumors, while the
-PKC transcript was present in only one Grade 2 tumor. Immunohistochemistry, using a monoclonal antibody to
-PKC, revealed diffuse, positive cytoplasmic signals in most cells of the Grade 1 tumors. Grade 2 tumors exhibited heterogeneity of
-PKC expression, although a significant percentage of cells showed positivity. In contrast, only a small number of differentiated cells within Grade 3 tumors were positive for
-PKC expression, with the more malignant, dedifferentiated cells uniformly negative. Throughout all tumor grades, the staining pattern of
-PKC closely paralleled that of glial fibrillary acidic protein.
Taken in conjunction with the established role of PKC in tumor promotion, these results suggest that the
-PKC isoenzyme plays a specific role in facilitating clonal expansion of transformed astrocytes in low-grade astrocytomas. Analysis of
-PKC may therefore serve as a direct biological marker of malignancy which may serve to enhance the current histopathological grading system.
1 Recipient of the Anthony Greto Fellowship from the Association for Brain Tumor Research.
2 To whom requests for reprints should be addressed, at Department of Clinical Neurosciences, Rhode Island Hospital, Aldrich 516, 593 Eddy Street, Providence, RI 02903.
Received 9/11/91. Accepted 3/10/92.
This article has been cited by other articles:
![]() |
D. J. Propper, A. C. McDonald, A. Man, P. Thavasu, F. Balkwill, J. P. Braybrooke, F. Caponigro, P. Graf, C. Dutreix, R. Blackie, et al. Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C J. Clin. Oncol., March 1, 2001; 19(5): 1485 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Clemens, I. Trayner, and J. Menaya The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation J. Cell Sci., December 1, 1992; 103(4): 881 - 887. [PDF] |
||||
![]() |
I. M. Hussaini, L. R. Karns, G. Vinton, J. E. Carpenter, G. T. Redpath, J. J. Sando, and S. R. VandenBerg Phorbol 12-Myristate 13-Acetate Induces Protein Kinase Ceta -specific Proliferative Response in Astrocytic Tumor Cells J. Biol. Chem., July 14, 2000; 275(29): 22348 - 22354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |